Tapewire

Nasdaq · USD

IPSC

Century Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5739
SEC CIK
0001850119
Parsed reports
187

Last 12 months

Inside the activity.

3 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202513
Dec 202522
Jan 202600
Feb 202601
Mar 202604
Apr 202600
May 202601
Jun 202604
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 09, 2022 Filed Jun 10, 2022 20:22 UTC
Casdin EliDirector
GrantStock Option (right to buy) · Derivative 19,872 $0.00 Strike: $8.56 $0.00
Disclosure

SEC source: 0001062993-22-014655 · form4.xml · derivative · entry 1

Casdin Eli · CIK 0001534264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,872

Underlying: Common Stock · 19,872 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 9, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:31 UTC OtherCommon Stock 178,996 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-004169 · doc4.xml · nonDerivative · entry 1

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,366,814

F1 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its limited partners.

F2 · ownership.direct: The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:51 UTC
Diem Michael CraigChief Business Officer
GrantStock Option (right to buy) · Derivative 105,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001691 · form4.xml · derivative · entry 1

Diem Michael Craig · CIK 0001497624 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:51 UTC
Farid AdrienneChief Operations Officer
GrantStock Option (right to buy) · Derivative 105,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001689 · form4.xml · derivative · entry 1

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:50 UTC
Borges LuisChief Scientific Officer
GrantStock Option (right to buy) · Derivative 105,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001688 · form4.xml · derivative · entry 1

Borges Luis · CIK 0001684015 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:50 UTC
Levitsky HyamPresident of R&D
GrantStock Option (right to buy) · Derivative 105,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001687 · form4.xml · derivative · entry 1

Levitsky Hyam · CIK 0001375792 · President of R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:50 UTC
Russotti GregoryChief Technology Officer
GrantStock Option (right to buy) · Derivative 105,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001686 · form4.xml · derivative · entry 1

Russotti Gregory · CIK 0001867305 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:49 UTC
Flores OsvaldoChief Executive Officer
GrantStock Option (right to buy) · Derivative 315,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001685 · form4.xml · derivative · entry 1

Flores Osvaldo · CIK 0001867301 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,000

Underlying: Common Stock · 315,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
January 25, 2022 Filed Jan 27, 2022 21:49 UTC
Carr DouglasVP of Finance and Operations
GrantStock Option (right to buy) · Derivative 35,000 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001062993-22-001684 · form4.xml · derivative · entry 1

Carr Douglas · CIK 0001867173 · VP of Finance and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 23, 2021 Filed Dec 28, 2021 21:46 UTC OtherCommon Stock 371,004 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-049938 · doc4.xml · nonDerivative · entry 1

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,545,810

F1 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its limited partners pursuant to a Rule 10b5-1 trading plan.

F2 · ownership.direct: The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 22, 2021 20:31 UTC
Casdin EliDirector
ConversionSeries C Preferred Stock · Derivative 6,180,500 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000569 · edgar.xml · derivative · entry 3

Casdin Eli · CIK 0001534264 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 2,456,380 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F1 · derivative.exercise_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F1 · derivative.expiration_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F2 · ownership.nature: Consists of (i) 1,228,190 shares of Common Stock directly held by Casdin Partners Master Fund, L.P. and (ii) 1,228,190 shares of Common Stock directly held by Casdin Private Growth Equity Fund, L.P. The securities owned directly by Casdin Partners Master Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. The securities owned directly by Casdin Private Growth Equity Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Private Growth Equity Fund, L.P., (ii) Casdin Private Growth Equity Fund GP, LLC, the general partner of Casdin Private Growth Equity Fund, L.P., and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Private Growth Equity Fund GP, LLC. Each of Casdin Capital, LLC, Casdin Private Growth Equity Fund GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 22, 2021 20:31 UTC
Casdin EliDirector
PurchaseCommon Stock 750,000 $20.00 $15,000,000.00
Disclosure

SEC source: 0001192482-21-000569 · edgar.xml · nonDerivative · entry 2

Casdin Eli · CIK 0001534264 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,206,380

F3 · ownership.nature: The shares reflected are beneficially owned by Casdin Partners Master Fund, L.P.. Such securities are owned directly by Casdin Partners Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 22, 2021 20:31 UTC
Casdin EliDirector
ConversionCommon Stock 2,456,380 Not disclosed Not disclosed
Disclosure

SEC source: 0001192482-21-000569 · edgar.xml · nonDerivative · entry 1

Casdin Eli · CIK 0001534264 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,456,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F2 · ownership.nature: Consists of (i) 1,228,190 shares of Common Stock directly held by Casdin Partners Master Fund, L.P. and (ii) 1,228,190 shares of Common Stock directly held by Casdin Private Growth Equity Fund, L.P. The securities owned directly by Casdin Partners Master Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. The securities owned directly by Casdin Private Growth Equity Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Private Growth Equity Fund, L.P., (ii) Casdin Private Growth Equity Fund GP, LLC, the general partner of Casdin Private Growth Equity Fund, L.P., and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Private Growth Equity Fund GP, LLC. Each of Casdin Capital, LLC, Casdin Private Growth Equity Fund GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 16:41 UTC ConversionSeries C Preferred Stock · Derivative 3,862,813 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-042752 · doc4.xml · derivative · entry 5

BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner

Bayer World Investments B.V. · CIK 0001820027 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,535,238 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F3 · price: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F3 · derivative.exercise_date: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F3 · derivative.expiration_date: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F3 · derivative.underlying_shares: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 16:41 UTC ConversionSeries B Preferred Stock · Derivative 26,143,790 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-042752 · doc4.xml · derivative · entry 4

BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner

Bayer World Investments B.V. · CIK 0001820027 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,390,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F1 · price: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F1 · derivative.exercise_date: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F1 · derivative.expiration_date: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F1 · derivative.underlying_shares: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 16:41 UTC PurchaseCommon Stock 750,000 $20.00 $15,000,000.00
Disclosure

SEC source: 0001209191-21-042752 · doc4.xml · nonDerivative · entry 3

BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner

Bayer World Investments B.V. · CIK 0001820027 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,675,838

F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 16:41 UTC ConversionCommon Stock 1,535,238 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-042752 · doc4.xml · nonDerivative · entry 2

BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner

Bayer World Investments B.V. · CIK 0001820027 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,925,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 16:41 UTC ConversionCommon Stock 10,390,600 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-042752 · doc4.xml · nonDerivative · entry 1

BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner

Bayer World Investments B.V. · CIK 0001820027 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,390,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date.

F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 21:00 UTC
FUJIFILM Corp10% owner
ConversionSeries A Convertible Preferred Stock · Derivative 10,000,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-21-006870 · ownership.xml · derivative · entry 2

FUJIFILM Cellular Dynamics, Inc. · CIK 0001868056 · 10% owner

FUJIFILM Corp · CIK 0001637891 · 10% owner

FUJIFILM Holdings America Corp · CIK 0001637886 · 10% owner

FUJIFILM Holdings Corp · CIK 0001537075 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,974,404 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

F1 · derivative.exercise_date: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

F1 · derivative.expiration_date: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

F1 · derivative.underlying_shares: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

F2 · ownership.direct: FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 21:00 UTC
FUJIFILM Corp10% owner
ConversionCommon Stock 3,974,404 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-21-006870 · ownership.xml · nonDerivative · entry 1

FUJIFILM Cellular Dynamics, Inc. · CIK 0001868056 · 10% owner

FUJIFILM Corp · CIK 0001637891 · 10% owner

FUJIFILM Holdings America Corp · CIK 0001637886 · 10% owner

FUJIFILM Holdings Corp · CIK 0001537075 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,955,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

F2 · ownership.direct: FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 20:30 UTC ConversionSeries C Preferred Stock · Derivative 1,545,125 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · derivative · entry 5

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 614,095 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F3 · derivative.exercise_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F3 · derivative.expiration_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F3 · derivative.underlying_shares: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F4 · ownership.nature: The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 20:30 UTC ConversionSeries A Preferred Stock · Derivative 25,000,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · derivative · entry 4

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,936,011 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F1 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F1 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F2 · ownership.direct: The reportable securities are owned directly by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 20:30 UTC PurchaseCommon Stock 100,000 $20.00 $2,000,000.00
Disclosure

SEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · nonDerivative · entry 3

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 714,095

F4 · ownership.nature: The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 20:30 UTC ConversionCommon Stock 614,095 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · nonDerivative · entry 2

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 614,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F4 · ownership.nature: The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
June 22, 2021 Filed Jun 23, 2021 20:30 UTC ConversionCommon Stock 9,936,011 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · nonDerivative · entry 1

Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner

Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner

Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner

Versant Vantage II, L.P. · CIK 0001832235 · 10% owner

Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner

Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,916,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.

F2 · ownership.direct: The reportable securities are owned directly by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 20:33 UTC GrantOption (right to buy) · Derivative 19,872 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001192482-21-000561 · edgar.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,872

Underlying: Common Stock · 19,872 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 20:34 UTC GrantOption (right to buy) · Derivative 19,872 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001192482-21-000562 · edgar.xml · derivative · entry 1

Blackwell Kimberly · CIK 0001816465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,872

Underlying: Common Stock · 19,872 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 20:33 UTC
Casdin EliDirector
Disposition to issuerOption (right to buy) · Derivative 39,744 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001192482-21-000560 · edgar.xml · derivative · entry 1

Casdin Eli · CIK 0001534264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,744

Underlying: Common Stock · 39,744 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 20:32 UTC GrantOption (right to buy) · Derivative 19,872 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001192482-21-000559 · edgar.xml · derivative · entry 1

BUTITTA CYNTHIA M · CIK 0001222082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,872

Underlying: Common Stock · 19,872 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 20:32 UTC GrantOption (right to buy) · Derivative 39,744 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001192482-21-000558 · edgar.xml · derivative · entry 1

Carlo Rizzuto · CIK 0001817033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,744

Underlying: Common Stock · 39,744 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 20:31 UTC GrantOption (right to buy) · Derivative 19,872 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001192482-21-000557 · edgar.xml · derivative · entry 1

Riva Alessandro · CIK 0001867172 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,872

Underlying: Common Stock · 19,872 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.